Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concise, accurate diagnosis and treatment evaluation of osteoporosis using new imaging techniques
ChiCTR-IPR-16009416Phase 4Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of alendronate in osteoporosis (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: Bone mineral density of lumbar spine, Fat fraction of bone marrow and 2 more. Planned start Dec 2016; status: not yet recruiting.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ChiCTR-IPR-16009416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009416.